A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
Item 1. Business. NovelStem International Corp. (“NovelStem” or the “Company”) is a holding company whose principal assets are a 50% equity interest in NetCo Partners (“NetCo”) and an approximately 31% interest in NewStem Ltd, an Israeli biotech company (“NewStem”). NovelStem was formerly known as Hollywood Media Corp. The Company was incorporated in the State of Florida on January 22, 1993 and changed its name to NovelStem International Corp. in September 2018. With the purchase of NewStem, the Company expanded its business focus from media to cutting edge biotech. As a significant shareholder in NewStem, and the substantial commitment of our management and financial resources to NewStem, including the fact that our Executive Chairman, Jan Loeb, is also the Chairman of NewStem, we have the ability to exert significant influence over the management and operations of NewStem resulting in NewStem functioning as a minority operating subsidiary of the Company.
| Metric | TTM | FY2023 | FY2022 | FY2021 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|
| Revenue | 0 | - | - | - | - | - |
| Net Income | 2.3M | -4.2M | -766K | -1.3M | 10M | -6.9M |
| EPS | $0.05 | $-0.09 | $-0.02 | $-0.03 | $0.45 | $-0.28 |
| Free Cash Flow | 0 | -348K | -182K | -220K | -4.0M | -2.7M |
| ROIC | -1282.4% | -157.6% | -34.5% | -52.8% | 41.7% | -47.0% |
| Gross Margin | - | 0.0% | 0.0% | 0.0% | - | - |
| Debt/Equity | 0.00 | -1.96 | 0.20 | 0.14 | 0.00 | 0.00 |
| Dividends/Share | $0.00 | $0.00 | $0.00 | $0.00 | - | - |
| Operating Income | -241K | -3.5M | -422K | -496K | -5.7M | -5.8M |
| Operating Margin | 0.0% | - | - | - | - | - |
| ROE | 0.0% | - | -39.6% | -55.7% | 52.7% | -47.1% |
| Shares Outstanding | 47M | 47M | 38M | 45M | 23M | 25M |
| Metric | 2009 | 2010 | 2011 | 2012 | 2021 | |||
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 4.5M | 4.0M | N/A | N/A | N/A | N/A | N/A | 0 |
| Gross Margin | 0.0% | -20.1% | N/A | N/A | 0.0% | 0.0% | 0.0% | N/A |
| R&D | N/A | N/A | N/A | N/A | 2.4M | 2.1M | 965K | 965K |
| SG&A | 4.3M | 3.7M | 2.8M | 2.9M | 496K | 744K | 665K | 185K |
| EBIT | -8.0M | -7.7M | -5.8M | -5.7M | -496K | -422K | -3.5M | -241K |
| Op. Margin | -177.2% | -191.8% | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Net Income | -5.6M | 4.9M | -6.9M | 10M | -1.3M | -766K | -4.2M | 2.3M |
| Net Margin | -124.4% | 122.8% | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Non-Recurring | 5.0M | -72K | 4.8M | 3.6M | 0 | 0 | 0 | 0 |
| Returns on Capital | ||||||||
| ROIC | -17.3% | 13.0% | -47.0% | 41.7% | -52.8% | -34.5% | -157.6% | N/M |
| ROE | -16.0% | 14.0% | -47.1% | 52.7% | -55.7% | -39.6% | N/A | 0.0% |
| ROA | N/A | 20.7% | -37.7% | 46.4% | -51.6% | -33.5% | -184.4% | 15530.8% |
| Cash Flow | ||||||||
| Op. Cash Flow | 4.0M | 3.9M | -2.6M | -3.9M | -181K | -182K | -348K | -181K |
| Free Cash Flow | 3.9M | 3.8M | -2.7M | -4.0M | -220K | -182K | -348K | 0 |
| Owner Earnings | 3.2M | 3.4M | -2.8M | -4.1M | -466K | -483K | -665K | -212K |
| CapEx | 102K | 142K | 90K | 84K | 39K | 0 | 0 | 0 |
| Maint. CapEx | 744K | 541K | 203K | 136K | 12K | 18K | 14K | 14K |
| Growth CapEx | 0 | 0 | 0 | 0 | 27K | N/A | N/A | 0 |
| D&A | 744K | 541K | 203K | 136K | 12K | 18K | 14K | 14K |
| CapEx/OCF | N/A | 3.6% | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Capital Allocation | ||||||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 73K | 0 | 16M | 2.7M | 0 | 0 | 0 | 0 |
| Buyback Yield | 0.0% | N/A | 144.7% | N/A | 0.0% | 0.0% | 0.0% | 0.0% |
| Stock-Based Comp | N/A | N/A | N/A | N/A | 273K | 283K | 303K | 18K |
| Debt Repayment | 0 | 0 | 59K | 22K | 100K | 100K | 250K | 250K |
| Balance Sheet | ||||||||
| Net Debt | N/A | -29M | -7.3M | -23M | 317K | 376K | 3.7M | 616K |
| Cash & Equiv. | 8.4M | 29M | 3.7M | 11M | 9K | 6K | 53K | 1K |
| Long-Term Debt | N/A | N/A | 16K | 2K | 134K | 288K | 3.3M | 3.3M |
| Debt/Equity | -0.03 | 0.00 | 0.00 | 0.00 | 0.14 | 0.20 | -1.96 | 0.00 |
| Interest Coverage | -192.4 | -270.4 | -5.5 | -4.6 | -72.6 | -38.3 | -35.6 | -35.6 |
| Equity | 32M | 38M | 15M | 25M | 2.4M | 1.9M | -2.0M | -2.1M |
| Total Assets | -10K | 47M | 18M | 27M | 2.6M | 2.3M | 2.3M | 15K |
| Total Liabilities | -938K | 9.6M | 3.6M | 1.7M | 193K | 353K | 4.2M | 2.1M |
| Intangibles | 5.0M | 15M | 9.8M | 6.2M | N/A | N/A | N/A | N/A |
| Retained Earnings | N/A | -272M | -279M | -269M | -288M | -289M | -293M | -294M |
| Working Capital | N/A | 22M | 3.1M | 12M | -156K | -6K | -260K | -23K |
| Current Assets | N/A | 31M | 5.5M | 14M | 37K | 59K | 87K | 15K |
| Current Liabilities | N/A | 9.3M | 2.5M | 1.6M | 193K | 65K | 346K | 38K |
| Per Share Data | ||||||||
| EPS | -0.18 | 0.16 | -0.28 | 0.45 | -0.03 | -0.02 | -0.09 | 0.05 |
| Owner EPS | 0.10 | 0.11 | -0.11 | -0.18 | -0.01 | -0.01 | -0.01 | -0.00 |
| Book Value | 1.04 | 1.23 | 0.59 | 1.08 | 0.05 | 0.05 | -0.04 | -0.04 |
| Cash Flow/Share | 0.13 | 0.13 | -0.11 | -0.17 | -0.00 | -0.00 | -0.01 | 0.05 |
| Dividends/Share | 0.00 | N/A | N/A | N/A | 0.00 | 0.00 | 0.00 | 0.00 |
| Shares Out. | 31.2M | 30.7M | 24.5M | 23.1M | 44.9M | 38.3M | 46.5M | 46.9M |
| Valuation | ||||||||
| P/E Ratio | N/A | 4.0 | N/A | 1.2 | N/A | N/A | N/A | 0.2 |
| P/FCF | N/A | 5.2 | N/A | N/A | N/A | N/A | N/A | N/A |
| EV/EBIT | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price/Book | N/A | 0.5 | 0.8 | 0.5 | N/A | N/A | N/A | N/A |
| Price/Sales | N/A | 3.7 | N/A | N/A | N/A | N/A | N/A | N/A |
| FCF Yield | N/A | 19.1% | -23.7% | -33.2% | N/A | N/A | N/A | N/A |
| Market Cap | 0 | 20M | 11M | 12M | 0 | 0 | 0 | 469K |
| Avg. Price | 0.00 | 0.48 | 0.62 | 0.49 | 0.00 | 0.00 | 0.00 | 0.01 |
| Year-End Price | 0.00 | 0.65 | 0.46 | 0.52 | 0.00 | 0.00 | 0.00 | 0.01 |
NovelStem International Corp. passes 1 of 9 quality checks, indicating weak fundamentals.
NovelStem International Corp. trades at 0.0x trailing earnings, compared to its 15-year median P/E of 2.6x, suggesting it is currently Cheap relative to its historical range. At current prices, the estimated annualized return to fair value is -18.0%.
NovelStem International Corp. (NSTM) has a current P/E ratio of 0.0, compared to its historical median P/E of 2.6. The stock is currently considered Cheap based on its historical valuation range.
NovelStem International Corp. (NSTM) has a 5-year average return on invested capital (ROIC) of -50.0%. This is below average and may indicate limited pricing power.
NovelStem International Corp. (NSTM) has a market capitalization of $469K. It is classified as a small-cap stock.
NovelStem International Corp. (NSTM) does not currently pay a regular dividend.
Based on historical P/E analysis, NovelStem International Corp. (NSTM) appears cheap. The current P/E of 0.0 is 100% below its historical median of 2.6. The estimated fair value CAGR (P/E method) is 0.0%.
NovelStem International Corp. (NSTM) operates in the Retail-Retail Stores, Nec industry, within the Consumer Cyclical sector.
NovelStem International Corp. (NSTM) generated $-348 thousand in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
NovelStem International Corp. (NSTM) reported earnings per share (EPS) of $-0.09 in its most recent fiscal year.
The Ledger Terminal provides 7 years of financial data for NovelStem International Corp. (NSTM), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
NovelStem International Corp. (NSTM) has a book value per share of $-0.04, based on its most recent annual SEC filing.
No recent press releases.